NLRP3 and Huntington disease: The use of a selective inhibitor of NLRP3 inflammasome in transgenic mouse of HD has been shown to reduce IL-1β and reactive oxygen species production, as well as reduce neuronal toxicity, reduce neuroinflammation, prolong life span and improve motor dysfunction [73].